David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$354M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$309M |
| 3 |
Microsoft
MSFT
|
+$307M |
| 4 |
Automatic Data Processing
ADP
|
+$266M |
| 5 |
Citigroup
C
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$567M |
| 2 |
Fidelity National Information Services
FIS
|
+$410M |
| 3 |
Medtronic
MDT
|
+$359M |
| 4 |
Amazon
AMZN
|
+$297M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.15% |
| 2 | Consumer Discretionary | 12.74% |
| 3 | Healthcare | 11.89% |
| 4 | Financials | 8.05% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
2176
CALL
Automatic Data Processing
ADP
$112B
| $2.39M | ﹤0.01% |
14,800
| – | – |
|
|
TVRD
2177
Tvardi Therapeutics
TVRD
$23.7M
| $2.39M | ﹤0.01% |
3,631
+2,419
| +200% | +$2.01M |
|
2178
First Financial Bankshares
FFIN
$4.83B
| $2.38M | ﹤0.01% |
71,404
-23,423
| -25% | -$737K |
|
2179
Ericsson
ERIC
$32.9B
| $2.38M | ﹤0.01% |
+297,967
| New | +$2.54M |
|
|
SAFM
2180
CALL
DELISTED
Sanderson Farms Inc
SAFM
| $2.38M | ﹤0.01% |
15,700
| – | – |
|
2181
CALL
Churchill Downs
CHDN
$6.1B
| $2.37M | ﹤0.01% |
+38,400
| New | +$2.32M |
|
2182
FirstService
FSV
$6.27B
| $2.37M | ﹤0.01% |
23,100
+10,900
| +89% | +$1.11M |
|
2183
Assembly Biosciences
ASMB
$721M
| $2.37M | ﹤0.01% |
20,056
+15,632
| +353% | +$2.36M |
|
|
MDR
2184
DELISTED
McDermott International
MDR
| $2.36M | ﹤0.01% |
1,168,707
-3,299,458
| -74% | -$20.3M |
|
2185
CALL
Takeda Pharmaceutical
TAK
$58.2B
| $2.35M | ﹤0.01% |
136,816
| – | – |
|
2186
PUT
Ternium
TX
$10.8B
| $2.35M | ﹤0.01% |
122,600
+50,900
| +71% | +$1.01M |
|
|
FSCT
2187
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $2.35M | ﹤0.01% |
61,969
-178,715
| -74% | -$6.53M |
|
2188
CALL
Truist Financial
TFC
$61.9B
| $2.35M | ﹤0.01% |
44,000
-80,000
| -65% | -$3.96M |
|
2189
PUT
Papa John's
PZZA
$777M
| $2.35M | ﹤0.01% |
44,800
-3,100
| -6% | -$146K |
|
2190
Arlo Technologies
ARLO
$1.41B
| $2.34M | ﹤0.01% |
686,047
+113,094
| +20% | +$411K |
|
|
ZVO
2191
DELISTED
Zovio Inc. Common Stock
ZVO
| $2.33M | ﹤0.01% |
1,183,349
-47,508
| -4% | -$143K |
|
2192
CALL
Ionis Pharmaceuticals
IONS
$10.5B
| $2.33M | ﹤0.01% |
38,900
| – | – |
|
|
SCPE.U
2193
DELISTED
SC Health Corporation Units, each consisting of one Class A ordinary share, $0.0001 par value, and o
SCPE.U
| $2.33M | ﹤0.01% |
+225,000
| New | +$2.32M |
|
2194
PUT
W.P. Carey
WPC
$16.2B
| $2.33M | ﹤0.01% |
26,546
+16,336
| +160% | +$1.39M |
|
|
LJPC
2195
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $2.32M | ﹤0.01% |
263,869
+112,429
| +74% | +$1.06M |
|
|
GNMK
2196
DELISTED
GenMark Diagnostics, Inc
GNMK
| $2.32M | ﹤0.01% |
382,726
+105,373
| +38% | +$658K |
|
2197
Dominion Energy
D
$58.8B
| $2.31M | ﹤0.01% |
28,490
-53,243
| -65% | -$4.12M |
|
2198
Enova International
ENVA
$5.89B
| $2.3M | ﹤0.01% |
111,030
-54,372
| -33% | -$1.28M |
|
2199
PUT
Fluor
FLR
$6.96B
| $2.3M | ﹤0.01% |
120,300
+82,100
| +215% | +$1.96M |
|
2200
PUT
Waste Management
WM
$88.4B
| $2.3M | ﹤0.01% |
20,000
+10,000
| +100% | +$1.17M |
|
Similar funds
David Shaw's Q3 2019 Portfolio in Review
As of Q3 2019, David Shaw held 4,189 positions worth $81.2B, up 1.3% from $80.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw withdrew a net $3.14B in Q3 2019, closing 422 positions and reducing 1,391 holdings. Its most notable exit was Anadarko Petroleum, an estimated $567M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $310M.
- David Shaw's largest Q3 2019 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 3,554,658 shares worth $310M.
- David Shaw added most to PayPal in Q3 2019, an estimated $354M increase.
- David Shaw's biggest Q3 2019 reduction was Fidelity National Information Services, cutting an estimated $410M.
- David Shaw fully exited Anadarko Petroleum in Q3 2019, selling an estimated $567M.
- David Shaw's ten largest holdings make up 10% of its $81.2B portfolio in Q3 2019.
- David Shaw opened 550 new positions and closed 422 in Q3 2019.
- David Shaw's portfolio value rose 1.3% quarter-over-quarter to $81.2B.
Based on D.E. Shaw & Co's 13F filing for Q3 2019, filed 14 Nov 2019.